These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 8923041)

  • 1. Interpretation of short-term test data: implications for assessment of chemopreventive activity.
    Waters MD; Stack HF; Jackson MA; Brockman HE
    IARC Sci Publ; 1996; (139):313-32. PubMed ID: 8923041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimutagenicity profiles for some model compounds.
    Waters MD; Brady AL; Stack HF; Brockman HE
    Mutat Res; 1990 Jan; 238(1):57-85. PubMed ID: 2406585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanistic considerations in the evaluation of chemopreventive data.
    Kelloff GJ; Boone CW; Steele VE; Crowell JA; Lubet RA; Greenwald P; Hawk ET; Fay JR; Sigman CC
    IARC Sci Publ; 1996; (139):203-19. PubMed ID: 8923032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term tests for defining mutagenic carcinogens.
    Waters MD; Stack HF; Jackson MA
    IARC Sci Publ; 1999; (146):499-536. PubMed ID: 10353401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimutagens as cancer chemopreventive agents in the diet.
    Ferguson LR
    Mutat Res; 1994 May; 307(1):395-410. PubMed ID: 7513820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of five dietary antimutagens on the genotoxicity of six mutagens in the microscreen prophage-induction assay.
    Cabrera G
    Environ Mol Mutagen; 2000; 36(3):206-20. PubMed ID: 11044902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity.
    Kirkland D; Aardema M; Henderson L; Müller L
    Mutat Res; 2005 Jul; 584(1-2):1-256. PubMed ID: 15979392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticarcinogenicity of monocyclic phenolic compounds.
    Williams GM; Iatropoulos MJ; Jeffrey AM
    Eur J Cancer Prev; 2002 Aug; 11 Suppl 2():S101-7. PubMed ID: 12570342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategy for genotoxicity testing: hazard identification and risk assessment in relation to in vitro testing.
    Thybaud V; Aardema M; Clements J; Dearfield K; Galloway S; Hayashi M; Jacobson-Kram D; Kirkland D; MacGregor JT; Marzin D; Ohyama W; Schuler M; Suzuki H; Zeiger E;
    Mutat Res; 2007 Feb; 627(1):41-58. PubMed ID: 17126066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity profiles of antimutagens: in vitro and in vivo data.
    Waters MD; Stack HF; Jackson MA; Brockman HE; De Flora S
    Mutat Res; 1996 Feb; 350(1):109-29. PubMed ID: 8657173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk biomarkers and current strategies for cancer chemoprevention.
    Kelloff GJ; Boone CW; Crowell JA; Nayfield SG; Hawk E; Malone WF; Steele VE; Lubet RA; Sigman CC
    J Cell Biochem Suppl; 1996; 25():1-14. PubMed ID: 9027592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Smokers and urinary genotoxins: implications for selection of cohorts and modulation of endpoints in chemoprevention trials.
    De Flora S; Camoirano A; Bagnasco M; Bennicelli C; van Zandwijk N; Wigbout G; Qian GS; Zhu YR; Kensler TW
    J Cell Biochem Suppl; 1996; 25():92-8. PubMed ID: 9027604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testing strategies in mutagenicity and genetic toxicology: an appraisal of the guidelines of the European Scientific Committee for Cosmetics and Non-Food Products for the evaluation of hair dyes.
    Kirkland DJ; Henderson L; Marzin D; Müller L; Parry JM; Speit G; Tweats DJ; Williams GM
    Mutat Res; 2005 Dec; 588(2):88-105. PubMed ID: 16326131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutagenicity assessment of acrylate and methacrylate compounds and implications for regulatory toxicology requirements.
    Johannsen FR; Vogt B; Waite M; Deskin R
    Regul Toxicol Pharmacol; 2008 Apr; 50(3):322-35. PubMed ID: 18346829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro anti-mutagenic effect of magnolol against direct and indirect mutagens.
    Saito J; Sakai Y; Nagase H
    Mutat Res; 2006 Oct; 609(1):68-73. PubMed ID: 16884943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimutagenic and anti-oxidant activities of the non-steroidal anti-inflammatory drug celecoxib.
    Ajith T; Subin JP; Jacob J; Sanjay PS; Babitha NV
    Clin Exp Pharmacol Physiol; 2005 Oct; 32(10):888-93. PubMed ID: 16173952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Meta-analysis of the Italian studies on short-term effects of air pollution].
    Biggeri A; Bellini P; Terracini B;
    Epidemiol Prev; 2001; 25(2 Suppl):1-71. PubMed ID: 11515188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of chrysin, a flavonoid compound, on the mutagenic activity of 2-amino-1-methyl-6-phenylimidazo[4,5- b]pyridine (PhIP) and benzo(a)pyrene (B(a)P) in bacterial and human hepatoma (HepG2) cells.
    Uhl M; Ecker S; Kassie F; Lhoste E; Chakraborty A; Mohn G; Knasmüller S
    Arch Toxicol; 2003 Aug; 77(8):477-84. PubMed ID: 12856103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tea antioxidants in cancer chemoprevention.
    Katiyar SK; Mukhtar H
    J Cell Biochem Suppl; 1997; 27():59-67. PubMed ID: 9591194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.